Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
Dow Jones Industrial Average
) is trading up 172 points (+1.1%) at 15,475 as of Tuesday, May 28, 2013, 9:35 a.m. ET. During this time, 34.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 594.8 million. The NYSE advances/declines ratio sits at 2,156 issues advancing vs. 342 declining with 115 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a $1.08 gain (+2.3%) bringing the stock to $48.24. This single gain is lifting the Dow Jones Industrial Average by 8.17 points or roughly accounting for 4.8% of the Dow's overall gain. Volume for Merck currently sits at 1.4 million shares traded vs. an average daily trading volume of 17.4 million shares.
Merck has a market cap of $142.4 billion and is part of the health care sector and drugs industry. Shares are up 15.2% year to date as of Friday's close. The stock's dividend yield sits at 3.6%.
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company has a P/E ratio of 24.1, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Merck as a
. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Merck Ratings Report.
Holding back the Dow today is
), which is lagging the broader index with a six-cent decline to $81.82. Volume for Procter & Gamble currently sits at 1.1 million shares traded vs. an average daily trading volume of 9.1 million shares.
Procter & Gamble has a market cap of $224.41 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 20.6% year to date as of Friday's close. The stock's dividend yield sits at 2.9%.
The Procter & Gamble Company, together with its subsidiaries, engages in the manufacture and sale of a range of branded consumer packaged goods. The company operates in five segments: Beauty, Grooming, Health Care, Fabric Care and Home Care, and Baby Care and Family Care. The company has a P/E ratio of 20.6, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Procter & Gamble as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, good cash flow from operations and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Procter & Gamble Ratings Report.
Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE